newsfilter
← Latest News
GlobeNewswire·

GH Research Announces Pricing of $117.5 Million Underwritten Offering

DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ:GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in